We don’t know whether they want to add new aircrafts to the company’s fleet or if they are simply trying to get rid of the maintenance costs; all we know is that they are selling two of the company’s corporate jets. Pharmaceutical giant Pfizer has revealed its plans to sell two of its Gulfstream jets for just $65 million. The amount doesn’t mean a lot to the world’s largest drug maker, but it’s a bargain for the intended buyers. Up for grabs are a Gulfstream V ($29.25 million) and the Gulfstream 550 ($35.5 million). Pricing for both the private jets has been reduced lately. Pfizer’s jets come with matching paint jobs and both of them are a great ride (see pics after the jump). Fierce Pharma cites…
CEO Jeffrey Kindler’s aircraft perks cost Pfizer $175,210 in 2008. Ian Read, the company’s worldwide pharma president, got $129,850 worth of aircraft use, while CFO Frank D’Amelio’s use only amounted to $70,505 and R&D chief Martin Mackay’s was $40,834.
Via: CityLife/Bnet